NCT00085254 2016-02-25
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 1/2 Completed
National Cancer Institute (NCI)
Merck KGaA, Darmstadt, Germany
National Cancer Institute (NCI)